US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Maze Therapeutics

29.60

+0.17000.58%

Volume:282.29K

Turnover:8.31M

Market Cap:1.64B

PE:-11.76

High:29.76

Open:29.27

Low:28.33

Close:29.43

52wk High:53.65

52wk Low:13.28

Shares:55.25M

Float Shares:37.25M

Volume Ratio:0.76

T/O Rate:0.76%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.5172

EPS(LYR):-3.0510

ROE:-37.35%

ROA:-21.79%

PB:3.61

PE(LYR):-9.70

Loading ...

Overview Company News Filings

Maze Therapeutics Inc : JP Morgan Raises Target Price to $58 From $52

THOMSON REUTERS

Calendar of U.S. Earnings Expected in the Week Ahead

Assessing Maze Therapeutics (MAZE) Valuation After Recent Share Price Weakness And Rich Price To Book Ratio

Simply Wall St.

Maze Therapeutics, Inc. (MAZE) Gets a Buy from LifeSci Capital

Stock Track | Maze Therapeutics Soars 5.17% Intraday on Analyst Insights

Analysts Offer Insights on Healthcare Companies: Zai Lab (ZLAB), Maze Therapeutics, Inc. (MAZE) and Compass Therapeutics (CMPX)

BUZZ-U.S. STOCKS ON THE MOVE-ADMA Biologics, Nanobiotix, DraftKings

Top Midday Decliners

MT Newswires Live

Maze Therapeutics share sell-off an ‘overreaction,’ says Raymond James

Maze Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Maze Therapeutics falls -33.2%

Leerink remains bullish on Maze, says Vertex comparison ‘apples to oranges’

Maze Therapeutics releases HORIZON MZE829 topline data call presentation; cash runway extends into 2028

Maze Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $110 From $60

THOMSON REUTERS

Maze Therapeutics Shares Plunge 21% Premarket After Q4 Results

THOMSON REUTERS

Maze Therapeutics Says Phase 2 Trial of Kidney Disease Therapy Shows Over 35% Protein Marker Reduction

MT Newswires Live

BUZZ-U.S. STOCKS ON THE MOVE-Arm, Destiny Tech100, Terns Pharma

BUZZ-Maze Therapeutics rises as kidney disease drug shows positive results in trial

Maze Therapeutics reports bigger-than-expected Q4 loss on higher R&D costs

Earnings Flash (MAZE) Maze Therapeutics Posts Q4 Net Loss $0.65 a Share, vs. FactSet Est of $0.72 Loss

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/MAZE/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MAZE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAZE\",,,,,undefined,":{"symbol":"MAZE","market":"US","secType":"STK","nameCN":"Maze Therapeutics","latestPrice":29.6,"timestamp":1787601600000,"preClose":29.43,"halted":0,"volume":282286,"delay":0,"changeRate":0.005776418620455376,"floatShares":37250300,"shares":55248700,"eps":-2.517242,"marketStatus":"Pre-Mkt","change":0.17,"latestTime":"08-25 07:22:01 EDT","open":29.27,"high":29.76,"low":28.3339,"amount":8307856.231609999,"amplitude":0.048457,"askPrice":34.86,"askSize":100,"bidPrice":29.59,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-2.517242,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787664600000},"marketStatusCode":1,"adr":0,"listingDate":1738299600000,"exchange":"NASDAQ","adjPreClose":29.6,"postHourTrading":{"tag":"盘后","latestPrice":29.6,"preClose":29.6,"latestTime":"19:30 EDT","volume":4913,"amount":145383.5,"timestamp":1787614207230,"change":0,"changeRate":0,"amplitude":0.007432},"volumeRatio":0.7594282190574012,"impliedVol":1.032,"impliedVolPercentile":0.8298},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAZE\",,,,,undefined,":{"symbol":"MAZE","floatShares":37250300,"roa":"-21.79%","roe":"-37.35%","lyrEps":-3.051003,"volumeRatio":0.7594282190574012,"shares":55248700,"dividePrice":0,"high":29.76,"amplitude":0.048457,"preClose":29.43,"low":28.3339,"week52Low":13.28,"pbRate":"3.61","psRate":"81.77","week52High":53.65,"institutionHeld":0,"latestPrice":29.6,"committee":-0.980198,"eps":-2.517242,"divideRate":0,"volume":282286,"delay":0,"ttmEps":-2.517242,"open":29.27,"prevYearClose":41.43,"prevWeekClose":29.43,"prevMonthClose":26.92,"prevQuarterClose":29.84,"fiveDayClose":27.95,"twentyDayClose":28.69,"sixtyDayClose":26.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MAZE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"MAZE","fiscalQuarterEnding":"2026/06","expectedEps":-0.76,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"post","actualEps":-0.76},{"market":"US","date":"2026-05-12","symbol":"MAZE","fiscalQuarterEnding":"2026/03","expectedEps":-0.43,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.45},{"market":"US","date":"2026-03-25","symbol":"MAZE","fiscalQuarterEnding":"2025/12","expectedEps":-0.73,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774411200000,"reportTimeType":"pre","actualEps":-0.65},{"market":"US","date":"2025-11-06","symbol":"MAZE","fiscalQuarterEnding":"2025/09","expectedEps":-0.74,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.66},{"market":"US","date":"2025-08-12","symbol":"MAZE","fiscalQuarterEnding":"2025/06","expectedEps":-0.79,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.77}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MAZE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MAZE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4167,"buy":0.5833,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5833,"analysts":12,"updateTime":1773979200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MAZE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MAZE","date":"2026-08-21","current":-11.758901,"percent":0.328205,"low":-19.775245,"twenty":-14.610658,"median":-10.685878,"eighty":9.273272,"high":14.99285,"avg":-4.856742,"sd":11.100913,"marketCap":1607037430},"quantilePoints":[{"date":"2025-01-31","current":12.681398,"twenty":12.46124,"median":12.543799,"eighty":12.626358,"marketCap":700431648},{"date":"2025-02-07","current":10.303636,"twenty":10.343265,"median":11.88881,"eighty":12.594654,"marketCap":569100714},{"date":"2025-02-14","current":8.972089,"twenty":9.94063,"median":10.40271,"eighty":12.302722,"marketCap":495555390},{"date":"2025-02-21","current":9.645788,"twenty":9.645788,"median":10.220414,"eighty":11.88881,"marketCap":532765822},{"date":"2025-02-28","current":10.081711,"twenty":9.495197,"median":10.081711,"eighty":10.604819,"marketCap":556843160},{"date":"2025-03-07","current":9.29705,"twenty":9.29705,"median":9.788453,"eighty":10.501783,"marketCap":513503951},{"date":"2025-03-14","current":8.956237,"twenty":8.972089,"median":9.582381,"eighty":10.303636,"marketCap":494679851},{"date":"2025-03-21","current":9.479345,"twenty":8.972089,"median":9.534826,"eighty":10.271932,"marketCap":523572656},{"date":"2025-03-28","current":8.93246,"twenty":8.956237,"median":9.495197,"eighty":10.168896,"marketCap":493366542},{"date":"2025-04-04","current":7.814885,"twenty":8.89283,"median":9.443679,"eighty":10.137192,"marketCap":408179251},{"date":"2025-04-11","current":6.372653,"twenty":8.695317,"median":9.384234,"eighty":10.081711,"marketCap":332850033},{"date":"2025-04-17","current":6.858987,"twenty":8.362362,"median":9.29705,"eighty":9.98026,"marketCap":358251746},{"date":"2025-04-25","current":6.456504,"twenty":7.783022,"median":9.224877,"eighty":9.897831,"marketCap":337229638},{"date":"2025-05-02","current":8.879789,"twenty":7.580103,"median":8.972089,"eighty":9.731387,"marketCap":463800243},{"date":"2025-05-09","current":8.40184,"twenty":7.63209,"median":8.956237,"eighty":9.655299,"marketCap":438836491},{"date":"2025-05-16","current":7.799992,"twenty":7.63958,"median":8.89283,"eighty":9.626766,"marketCap":405123785},{"date":"2025-05-23","current":8.575775,"twenty":7.65241,"median":8.850167,"eighty":9.590307,"marketCap":445417178},{"date":"2025-05-30","current":10.26226,"twenty":7.715941,"median":8.87535,"eighty":9.631522,"marketCap":533011510},{"date":"2025-06-06","current":11.248853,"twenty":7.782471,"median":8.89283,"eighty":9.769431,"marketCap":584254194},{"date":"2025-06-13","current":11.425934,"twenty":7.799992,"median":8.956237,"eighty":10.149874,"marketCap":593451599},{"date":"2025-06-20","current":9.494909,"twenty":7.805949,"median":9.034945,"eighty":10.238649,"marketCap":493156089},{"date":"2025-06-27","current":10.742908,"twenty":7.871903,"median":9.097801,"eighty":10.238649,"marketCap":557975894},{"date":"2025-07-03","current":9.697287,"twenty":7.967493,"median":9.217791,"eighty":10.255514,"marketCap":503667409},{"date":"2025-07-11","current":13.188311,"twenty":8.01948,"median":9.285161,"eighty":10.297295,"marketCap":684987676},{"date":"2025-07-18","current":14.385715,"twenty":8.08904,"median":9.384234,"eighty":10.584212,"marketCap":747179651},{"date":"2025-07-25","current":13.871337,"twenty":8.197097,"median":9.417731,"eighty":10.84241,"marketCap":720463380},{"date":"2025-08-01","current":12.437825,"twenty":8.267679,"median":9.479345,"eighty":11.289329,"marketCap":646008198},{"date":"2025-08-08","current":11.231989,"twenty":8.274387,"median":9.503122,"eighty":11.660356,"marketCap":583378251},{"date":"2025-08-15","current":-4.846264,"twenty":8.197097,"median":9.495197,"eighty":11.50014,"marketCap":585409301},{"date":"2025-08-22","current":-4.802702,"twenty":7.843394,"median":9.46183,"eighty":11.412442,"marketCap":580147195},{"date":"2025-08-29","current":-5.180239,"twenty":7.675693,"median":9.408012,"eighty":11.34667,"marketCap":625752114},{"date":"2025-09-05","current":-5.459761,"twenty":7.605258,"median":9.384234,"eighty":11.299448,"marketCap":659517295},{"date":"2025-09-12","current":-9.002797,"twenty":7.051844,"median":9.285161,"eighty":11.248853,"marketCap":1087501923},{"date":"2025-09-19","current":-8.523616,"twenty":6.791906,"median":9.217791,"eighty":11.231989,"marketCap":1029618756},{"date":"2025-09-26","current":-9.565472,"twenty":6.372653,"median":9.072896,"eighty":11.223556,"marketCap":1155470793},{"date":"2025-10-03","current":-9.619925,"twenty":-4.846264,"median":8.956237,"eighty":11.080205,"marketCap":1162048426},{"date":"2025-10-10","current":-10.440341,"twenty":-4.897086,"median":8.912645,"eighty":10.903124,"marketCap":1261151423},{"date":"2025-10-17","current":-10.327806,"twenty":-5.035032,"median":8.87091,"eighty":10.852529,"marketCap":1247557649},{"date":"2025-10-24","current":-10.854179,"twenty":-5.43435,"median":8.743704,"eighty":10.801935,"marketCap":1311141431},{"date":"2025-10-31","current":-12.059392,"twenty":-5.764695,"median":8.710535,"eighty":10.776638,"marketCap":1456726366},{"date":"2025-11-07","current":-10.301208,"twenty":-8.440123,"median":8.622163,"eighty":10.742908,"marketCap":1299301692},{"date":"2025-11-14","current":-12.147078,"twenty":-8.530877,"median":8.52824,"eighty":10.604819,"marketCap":1532123096},{"date":"2025-11-21","current":-13.570087,"twenty":-9.148004,"median":8.467465,"eighty":10.501783,"marketCap":1711608623},{"date":"2025-11-28","current":-14.401765,"twenty":-9.516102,"median":8.389744,"eighty":10.458575,"marketCap":1816509011},{"date":"2025-12-05","current":-16.252058,"twenty":-9.864597,"median":8.267679,"eighty":10.366822,"marketCap":2049888314},{"date":"2025-12-12","current":-15.096102,"twenty":-10.151143,"median":8.122944,"eighty":10.312226,"marketCap":1904086399},{"date":"2025-12-19","current":-15.496681,"twenty":-10.373183,"median":7.957431,"eighty":10.278273,"marketCap":1954611815},{"date":"2025-12-26","current":-16.053676,"twenty":-10.591356,"median":7.799992,"eighty":10.266129,"marketCap":2024866203},{"date":"2026-01-02","current":-15.805699,"twenty":-10.832398,"median":7.756189,"eighty":10.248768,"marketCap":1993588564},{"date":"2026-01-09","current":-14.859569,"twenty":-11.164921,"median":7.639287,"eighty":10.225157,"marketCap":1874252343},{"date":"2026-01-16","current":-15.187663,"twenty":-11.722514,"median":7.479482,"eighty":10.213352,"marketCap":1915635065},{"date":"2026-01-23","current":-17.625471,"twenty":-12.065201,"median":7.127309,"eighty":10.196366,"marketCap":2223118312},{"date":"2026-01-30","current":-17.167667,"twenty":-12.419472,"median":6.955415,"eighty":10.162555,"marketCap":2165374980},{"date":"2026-02-06","current":-16.767088,"twenty":-13.567798,"median":6.791906,"eighty":10.126096,"marketCap":2114849563},{"date":"2026-02-13","current":-17.945934,"twenty":-14.175152,"median":6.511006,"eighty":10.056348,"marketCap":2263538645},{"date":"2026-02-20","current":-17.182927,"twenty":-14.401765,"median":6.360075,"eighty":9.954897,"marketCap":2167299757},{"date":"2026-02-27","current":-17.48813,"twenty":-14.737488,"median":-4.831743,"eighty":9.883564,"marketCap":2205795312},{"date":"2026-03-06","current":-17.282118,"twenty":-15.149512,"median":-4.864415,"eighty":9.832206,"marketCap":2179810813},{"date":"2026-03-13","current":-19.775245,"twenty":-15.332634,"median":-4.897086,"eighty":9.697287,"marketCap":2494271379},{"date":"2026-03-20","current":-18.857728,"twenty":-15.469975,"median":-4.962429,"eighty":9.697287,"marketCap":2378544116},{"date":"2026-03-27","current":-12.021519,"twenty":-15.550091,"median":-5.100375,"eighty":9.693343,"marketCap":1576261545},{"date":"2026-04-02","current":-11.013091,"twenty":-15.507363,"median":-5.260102,"eighty":9.683007,"marketCap":1444036514},{"date":"2026-04-10","current":-10.569535,"twenty":-15.475316,"median":-5.486987,"eighty":9.652715,"marketCap":1385877385},{"date":"2026-04-17","current":-10.186635,"twenty":-15.415039,"median":-5.764695,"eighty":9.626766,"marketCap":1335671640},{"date":"2026-04-24","current":-10.959561,"twenty":-15.395201,"median":-7.129635,"eighty":9.621519,"marketCap":1437017594},{"date":"2026-05-01","current":-11.209856,"twenty":-15.384518,"median":-8.456458,"eighty":9.590184,"marketCap":1469836362},{"date":"2026-05-08","current":-10.741725,"twenty":-15.342553,"median":-8.527247,"eighty":9.573739,"marketCap":1408454934},{"date":"2026-05-15","current":-11.93693,"twenty":-15.289905,"median":-9.002797,"eighty":9.561199,"marketCap":1462775248},{"date":"2026-05-22","current":-11.629812,"twenty":-15.205975,"median":-9.258724,"eighty":9.520559,"marketCap":1425140470},{"date":"2026-05-29","current":-11.92338,"twenty":-15.178506,"median":-9.458383,"eighty":9.511048,"marketCap":1461114890},{"date":"2026-06-05","current":-11.471737,"twenty":-15.158668,"median":-9.619925,"eighty":9.501537,"marketCap":1405769629},{"date":"2026-06-12","current":-10.880085,"twenty":-15.117466,"median":-9.821399,"eighty":9.495024,"marketCap":1333267337},{"date":"2026-06-18","current":-11.218817,"twenty":-15.001489,"median":-9.973866,"eighty":9.488683,"marketCap":1374776283},{"date":"2026-06-26","current":-12.203399,"twenty":-14.845835,"median":-10.113627,"eighty":9.465333,"marketCap":1495428952},{"date":"2026-07-02","current":-13.463484,"twenty":-14.807685,"median":-10.175262,"eighty":9.440942,"marketCap":1649842230},{"date":"2026-07-10","current":-14.642273,"twenty":-14.807685,"median":-10.243922,"eighty":9.423562,"marketCap":1794293361},{"date":"2026-07-17","current":-12.268888,"twenty":-14.735962,"median":-10.345957,"eighty":9.406427,"marketCap":1503454015},{"date":"2026-07-24","current":-12.506,"twenty":-14.713835,"median":-10.387794,"eighty":9.396916,"marketCap":1532510277},{"date":"2026-07-31","current":-12.478902,"twenty":-14.649742,"median":-10.467027,"eighty":9.384234,"marketCap":1529189561},{"date":"2026-08-07","current":-12.88538,"twenty":-14.642273,"median":-10.571027,"eighty":9.336679,"marketCap":1579000296},{"date":"2026-08-14","current":-11.503614,"twenty":-14.638297,"median":-10.649147,"eighty":9.29705,"marketCap":1536767732},{"date":"2026-08-21","current":-12.029624,"twenty":-14.610658,"median":-10.685878,"eighty":9.273272,"marketCap":1607037430}],"updateTime":1787643315699},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MAZE\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2623337219","title":"Maze Therapeutics Inc : JP Morgan Raises Target Price to $58 From $52","url":"https://stock-news.laohu8.com/highlight/detail?id=2623337219","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623337219?lang=en_us&edition=fundamental","pubTime":"2026-03-31 12:21","pubTimestamp":1774930879,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nFWN40J08C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623315199","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2623315199","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623315199?lang=en_us&edition=fundamental","pubTime":"2026-03-30 18:00","pubTimestamp":1774864800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·INmune Bio Inc.                                 4Q      (.26)  4:05 PM. ·Dave & Buster                                   4Q       .39   4:05 PM. ·NIKE Class B                                     3Q       .29   4:15 PM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNN","BTBT","CAG","AIRJ","AIRO","BIRD","FDS","NKLR","PENG","BCAX","FC","KEEL","MKC","AEHR","JILL","MSM","CRDL","LW","PLAY","RNXT","PHR","BNZI","NEOG","BEEM","SGML","CALM","PRPL","BHST","NCNO","SGMO","DMAC","MAZE","NGEN","NNOX","PVH","BITF","APOG","IMNN","RH","BYND","PRGS","ANGO","AURA","AYI","NKE","NMRA","MKC.V","INV","PVLA","INMB","PROP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623366928","title":"Assessing Maze Therapeutics (MAZE) Valuation After Recent Share Price Weakness And Rich Price To Book Ratio","url":"https://stock-news.laohu8.com/highlight/detail?id=2623366928","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623366928?lang=en_us&edition=fundamental","pubTime":"2026-03-30 07:14","pubTimestamp":1774826075,"startTime":"0","endTime":"0","summary":"Maze Therapeutics (MAZE) has drawn attention after recent trading saw the share price close at US$30.38. Returns over the past month and past 3 months have both shown double digit declines.\nSee our latest analysis for Maze Therapeutics.\nThe recent weakness, including a 4.19% one day and 36.75% seven day share price decline, comes after a very large 1 year total shareholder return of 166.02%. This suggests that momentum has cooled even as longer term holders remain well ahead.\nIf Maze's swings...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-maze/maze-therapeutics/news/assessing-maze-therapeutics-maze-valuation-after-recent-shar","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-maze/maze-therapeutics/news/assessing-maze-therapeutics-maze-valuation-after-recent-shar","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622384780","title":"Maze Therapeutics, Inc. (MAZE) Gets a Buy from LifeSci Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2622384780","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622384780?lang=en_us&edition=fundamental","pubTime":"2026-03-28 22:37","pubTimestamp":1774708672,"startTime":"0","endTime":"0","summary":"In a report released today, Rami Katkhuda from LifeSci Capital maintained a Buy rating on Maze Therapeutics, Inc., with a price target of $57.00. K...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maze-therapeutics-inc-maze-gets-a-buy-from-lifesci-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maze-therapeutics-inc-maze-gets-a-buy-from-lifesci-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113012684","title":"Stock Track | Maze Therapeutics Soars 5.17% Intraday on Analyst Insights","url":"https://stock-news.laohu8.com/highlight/detail?id=1113012684","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113012684?lang=en_us&edition=fundamental","pubTime":"2026-03-26 22:28","pubTimestamp":1774535319,"startTime":"0","endTime":"0","summary":"Maze Therapeutics (MAZE) experienced a significant intraday surge of 5.17% during Thursday's trading session, indicating strong investor interest.The upward movement is attributed to recent analyst...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622985050","title":"Analysts Offer Insights on Healthcare Companies: Zai Lab (ZLAB), Maze Therapeutics, Inc. (MAZE) and Compass Therapeutics (CMPX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622985050","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622985050?lang=en_us&edition=fundamental","pubTime":"2026-03-26 20:41","pubTimestamp":1774528862,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zai Lab (ZLAB), Maze Therapeutics, Inc. (MAZE) and C...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zai-lab-zlab-maze-therapeutics-inc-maze-and-compass-therapeutics-cmpx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-zai-lab-zlab-maze-therapeutics-inc-maze-and-compass-therapeutics-cmpx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZLAB","XBI","BK4139","XLV","BK4007","BK4137","LABU","LU2488822045.USD","LU0128526141.USD","BK4531","MAZE","LU0029874061.USD","BK4585","BK4588","BK4526","CMPX","BK4581","BK4548","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622400500","title":"BUZZ-U.S. STOCKS ON THE MOVE-ADMA Biologics, Nanobiotix, DraftKings","url":"https://stock-news.laohu8.com/highlight/detail?id=2622400500","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622400500?lang=en_us&edition=fundamental","pubTime":"2026-03-26 01:47","pubTimestamp":1774460843,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-ADMA Biologics, Nanobiotix, DraftKingsWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call new","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nL6N40D0LO:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVN","SRPT","IMNN","NBHC","NOV","MPC","CTAS","BEAM","TXG","CORT","ADMA","BZAI","SIDU","SATL","DINO","VLO","KBH","TERN","MAZE","GPRO","ELVN","JBLU","GNRC","RGR","VNO","CHWY","PSX","LBRT","ARE","DKNG","BXP","PAYX","LMT","BWXT","BG","SLG"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2622005426","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2622005426","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622005426?lang=en_us&edition=fundamental","pubTime":"2026-03-26 01:35","pubTimestamp":1774460110,"startTime":"0","endTime":"0","summary":"Maze Therapeutics  said Wednesday its experimental oral medication demonstrated a 35.6% average reduction in a key marker of kidney damage during a Phase 2 clinical trial.The stock fell 32% as intraday volume topped 6.26 million shares, compared with the daily average of 488,452.Anavex Life Sciences  withdrew its application for marketing authorization of its experimental drug blarcamesine in the EU as an add-on treatment for early Alzheimer's disease in adults.The company said the decision follows feedback from the European Medicines Agency's Committee for Medicinal Products for Human Use, indicating it would not be in a position to issue a positive opinion.The stock fell 31% as volume topped 9.92 million shares, versus the daily average of 1.38 million.Micron Technology  commenced offers to purchase six series of outstanding senior notes, with maturities ranging from 2031 to 2035.The stock fell 3.9% as volume topped 41.3 million shares, versus the daily average of almost 36.4 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0154236417.USD","BK4588","LU1267930813.SGD","LU0203345920.USD","LU0889566641.SGD","BK4533","BK4553","LU0109392836.USD","LU2360106780.USD","IE0002270589.USD","LU0081259029.USD","LU2089985449.USD","BK4543","LU1852331112.SGD","IE00B7SZLL34.SGD","LU2054465674.USD","LU2250418816.HKD","BK4575","IE00B19Z3581.USD","LU1323610961.USD","LU2211815571.USD","AVXL","BK4554","LU2286300806.USD","LU2458330169.SGD","LU0056508442.USD","LU1316542783.SGD","LU2931357623.SGD","LU0203347892.USD","LU0157215616.USD","IE00B19Z3B42.SGD","LU0719512351.SGD","LU1803068979.SGD","BK4605","LU0889565833.HKD","GB00BDT5M118.USD","BK4139","BK4007","BK4512","LU0127658192.USD","IE00B5949003.HKD","LU0082616367.USD","MUD","LU0792757196.USD","BK4532","IE0009356076.USD","LU2048586759.USD","MAZE","MULL","LU1366333091.USD","BK4527","BK4566","LU0274383776.USD","BK4141","BK4579","LU2458330243.SGD","BK4585","LU0642271901.SGD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2622407079","title":"Maze Therapeutics share sell-off an ‘overreaction,’ says Raymond James","url":"https://stock-news.laohu8.com/highlight/detail?id=2622407079","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622407079?lang=en_us&edition=fundamental","pubTime":"2026-03-25 23:36","pubTimestamp":1774452961,"startTime":"0","endTime":"0","summary":"Raymond James reiterates a Strong Buy rating and $56 price target on Maze Therapeutics (MAZE) after the company announced data from the ongoing Pha...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maze-therapeutics-share-sell-off-an-overreaction-says-raymond-james-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maze-therapeutics-share-sell-off-an-overreaction-says-raymond-james-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU1804176565.USD","LU2265009873.SGD","RJF","LU1363072403.SGD","BK4585","MAZE","BK4007","BK4127","IE00B3QW5Z07.USD","LU0971096721.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622507036","title":"Maze Therapeutics Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2622507036","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622507036?lang=en_us&edition=fundamental","pubTime":"2026-03-25 23:17","pubTimestamp":1774451820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MAZE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 25, 2026 11:17 ET (15:17 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622005074","title":"Maze Therapeutics falls -33.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622005074","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622005074?lang=en_us&edition=fundamental","pubTime":"2026-03-25 22:06","pubTimestamp":1774447607,"startTime":"0","endTime":"0","summary":"Maze Therapeutics (MAZE) is down -33.2%, or -$16.28 to $32.72. Published first on TheFly – the ultimate source for real-time, market-moving breakin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maze-therapeutics-falls-33-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maze-therapeutics-falls-33-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAZE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622307164","title":"Leerink remains bullish on Maze, says Vertex comparison ‘apples to oranges’","url":"https://stock-news.laohu8.com/highlight/detail?id=2622307164","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622307164?lang=en_us&edition=fundamental","pubTime":"2026-03-25 21:36","pubTimestamp":1774445775,"startTime":"0","endTime":"0","summary":"Leerink says investors seem to be comparing Maze‘s (MAZE) MZE829 waterfall plot to the one seen with Vertex’s (VRTX) inaxaplin. The firm understand...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/leerink-remains-bullish-on-maze-says-vertex-comparison-apples-to-oranges-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/leerink-remains-bullish-on-maze-says-vertex-comparison-apples-to-oranges-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJT1NW94.SGD","LU0757428866.USD","LU0417517546.SGD","BK4533","LU0109394709.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","LU2236285917.USD","SG9999013999.USD","LU0256863811.USD","LU0058720904.USD","VERX","IE00B4R5TH58.HKD","BK4567","SG9999001176.SGD","BK4007","BK4139","IE00BFTCPJ56.SGD","LU1674673691.USD","LU2362540622.SGD","LU0079474960.USD","LU1093756168.USD","LU2237438978.USD","IE0002141913.USD","LU0823416689.USD","MAZE","LU1093756325.SGD","SGXZ57979304.SGD","LU1778281490.HKD","LU2456880835.USD","LU0889565916.HKD","IE00B19Z9P08.USD","LU1559883803.SGD","LU2462157665.USD","LU2362541273.HKD","IE00B894F039.SGD","LU1069344957.HKD","LU0289739699.SGD","BK4023","LU1674673428.USD","IE00B2B36J28.USD","VRTX","IE00B19Z9Z06.USD","IE00BZ9MQY76.HKD","LU0566484027.USD","IE00B19Z3581.USD","BK4585","BK4588","LU2362541513.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622079765","title":"Maze Therapeutics releases HORIZON MZE829 topline data call presentation; cash runway extends into 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2622079765","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622079765?lang=en_us&edition=fundamental","pubTime":"2026-03-25 21:24","pubTimestamp":1774445096,"startTime":"0","endTime":"0","summary":"Maze Therapeutics released a HORIZON MZE829 topline data call presentation covering its oral APOL1 inhibitor program for APOL1-mediated kidney disease.HORIZON Phase 2 results showed mean uACR reduction narrows by 36% in broad AMKD and drops by 62% in the FSGS subset.Response rate climbs to 50% for achieving at least a 30% uACR reduction, and safety data reported 0 serious adverse events.Operating capital is expected to extend into 2028 under the current business plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maze Therapeutics Inc. published the original content used to generate this news brief on March 25, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL5S3cr1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAZE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622207975","title":"Maze Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $110 From $60","url":"https://stock-news.laohu8.com/highlight/detail?id=2622207975","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622207975?lang=en_us&edition=fundamental","pubTime":"2026-03-25 21:24","pubTimestamp":1774445065,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nAZN4SN51T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622076005","title":"Maze Therapeutics Shares Plunge 21% Premarket After Q4 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2622076005","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622076005?lang=en_us&edition=fundamental","pubTime":"2026-03-25 21:02","pubTimestamp":1774443742,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nFWN40D0DK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAZE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622078469","title":"Maze Therapeutics Says Phase 2 Trial of Kidney Disease Therapy Shows Over 35% Protein Marker Reduction","url":"https://stock-news.laohu8.com/highlight/detail?id=2622078469","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622078469?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:45","pubTimestamp":1774439143,"startTime":"0","endTime":"0","summary":"Maze Therapeutics (MAZE) said Wednesday its experimental oral medication demonstrated a 35.6% average reduction in a key marker of kidney damage during a phase 2 clinical trial.According to the compan","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MAZE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622078483","title":"BUZZ-U.S. STOCKS ON THE MOVE-Arm, Destiny Tech100, Terns Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2622078483","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622078483?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:45","pubTimestamp":1774439135,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Arm, Destiny Tech100, Terns PharmaWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nL6N40D0SB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRAY","DKNX","XOMX","RKLX","LU1267930813.SGD","LU2087621335.USD","SIDU","IE00B19Z3B42.SGD","MAZE","NEMG","UFO","RKLZ","ARE","LU0122376428.USD","LU1934455194.USD","DKUP","DVN","SATL","ARMG","ASTN","DKNG","JPMO","ADMA","ARMW","DXYZ","LU2324357040.USD","TERN","ONON","LU1023059063.AUD","XOMZ","LU2237443382.USD","LU0861579265.USD","ARMU","ARM","LU1032466523.USD","XOMO","IE00BMPRXN33.USD","MRK","LU1066053197.SGD","BEAM","IE00B19Z3581.USD","ASTX","NWMX","LU0868494708.USD","NEM"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2622020928","title":"BUZZ-Maze Therapeutics rises as kidney disease drug shows positive results in trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2622020928","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622020928?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:15","pubTimestamp":1774437313,"startTime":"0","endTime":"0","summary":"BUZZ-Maze Therapeutics rises as kidney disease drug shows positive results in trial** Shares of biotech firm Maze Therapeutics MAZE.O rise 3.1% to $50.50 premarket** Co says its experimental drug MZE829 reduced protein in urine, a key sign of kidney damage, in a midstage study** Drug targets APOL1mediated kidney disease, an inherited kidney condition that can lead to kidney failure** Study showed an average 35.6% drop in urine protein after 12 weeks; about half of patients saw drops of over 30%, co says** Adds larger reductions were seen in patients with a severe kidney scarring condition and those without diabetes** Co says it plans a larger, latestage study of MZE829 following the results** As of last close, stock was up ~18% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nL4N40D105:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAZE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622549020","title":"Maze Therapeutics reports bigger-than-expected Q4 loss on higher R&D costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2622549020","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622549020?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:10","pubTimestamp":1774437021,"startTime":"0","endTime":"0","summary":"Maze Therapeutics reports bigger-than-expected Q4loss on higher R&D costsOverviewUS biopharmaceutical firm's Q4 net loss missed analyst expectations, income from operations also missedPretax profit fo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nL1N40D0DF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MAZE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622020399","title":"Earnings Flash (MAZE) Maze Therapeutics Posts Q4 Net Loss $0.65 a Share, vs. FactSet Est of $0.72 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2622020399","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622020399?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:07","pubTimestamp":1774436852,"startTime":"0","endTime":"0","summary":"Earnings Flash (MAZE) Maze Therapeutics Posts Q4 Net Loss $0.65 a Share, vs. FactSet Est of $0.72 Loss","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MAZE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":120,"code":"91000000","status":"200"}]}}